This invention relates to a method and apparatus for providing improved detection of an analyte by photoionization in a vacuum laser/mass spectrometry chamber. The invention allows for direct injection of a liquid sample into such a chamber.
Analytes in gases may be analyzed by vacuum laser photoinization and mass spectrometry. This technique is termed resonance enhanced multi-photonionization (REMPI) spectroscopy. Typically, a tunable dye laser (the pump laser) is scanned over the vibrational levels of the selected state while a second fixed wavelength laser (the probe laser) is used to induce ionization. When the pump laser is resonant, there is a great increase in ionization cross-section for a given photon flux, giving increased ion yield. The difference in ion yield between non-resonant and resonant absorption is used as a basis to record the REMPI spectrum. Once the sample is ionized, the ions are extracted to a mass spectrometer detector. By proper tuning the probe laser photoionizes the molecules of analytical interest. Analysis is performed by time-of-flight mass spectrometry with high efficiency and selectivity.
In particular, by using biological samples such as blood plasma, saliva and skin, it is feasible to detect biological analytes in such complex matrices at very low concentrations. However, detection limits using a typical REMPI system on biological analytes in such samples appear to about 0.2 to 1.0 μg/ml. Being that such biological samples are liquids, accuracy below this limit is compromised by absorption at the inlet system. Furthermore, absorption requires frequent cleaning of the system leading to slow turn around time. It would thus be desirable to avoid this problem and also to improve the inlet system such that liquid analytes may be analyzed to much lower limits of detection, such as those required for analyzing biological samples.
The present invention provides a method for analyzing an analyte at low concentration in a liquid sample by laser photoionization/mass spectrometry comprising the steps of (a) introducing a liquid sample containing the analyte into a capillary tube having a proximal end for receiving a liquid sample and a distal end for exit of the sample into a region of atmospheric or subatmospheric pressure; (b) forming the liquid sample exiting the distal end into a directed stream of droplets along a path toward a zone of photoionization under a gradient of successively lower pressure such that substantial condensation of the analyte along the path is avoided; (c) directing the stream into the zone of photoionization to ionize the analyte to form analyte ions; (d) passing the analyte ions into a mass analyzer of a mass spectrometer for analysis of the ions.
The preferred apparatus for performing this method comprises (a) a capillary tube for introducing a liquid sample into a region of atmospheric or subatmospheric pressure; (b) a zone of photoionization for irradiating evaporated droplets of the sample at subatmospheric pressure to ionize ionizable species; (c) a region characterized by a gradient of successively lower pressure along a path from the capillary tube to the zone of photoionization; (d) a collimator for directing a collimated stream of evaporated droplets of the sample along the path through the region of successively lower pressures toward the zone of photoionization such that condensation of the analyte along the path is substantially avoided and; (e) a mass spectrometer for determining the m/e ratio of ions formed by irradiating the sample.
The preferred system for analyzing the analyte is a photoionization/REMPI mass spectrometry system. A detectable limit for quantitative determination of an analyte in a liquid sample will be as low as about 10−4 μg/ml concentration of analyte in the sample.
The evaporated droplets of the liquid sample are preferably directed into the zone of photoionization at an average chamber pressure of 10−5 to 10−4 torr. Upon exit from the collimator, the distance from the collimator to the zone of irradiation is preferably in the range of about 12 to about 0.5 cm.
Photoionization is preferably performed by a laser, typically a tunable laser. The term “capillary tube” includes, but is not limited to, a nanotube, a small gas chromatography column, and a liquid chromatograph capillary inlet.
If using a photoionization/mass spectrometry system, due to the close proximity of the droplet stream to the zone of irradiation, there may not be enough cooling of the sample to allow a signature spectrum to be taken. However, there are at least two alternative ways to identify the presence of the analyte. Firstly, one may inject a sample having a higher concentration of analyte and use a supersonic jet-cooled inlet to measure a jet-cooled spectrum to determine of anything else appears at the same atomic mass in the sample. If no interferences are found, then the sample may be injected using the mass as a sole identification criterion.
Alternatively, one may separate the sample using liquid chromatographic separation. Following this by photoionization/REMPI detection instead of conventional mass spectroscopy or fluorescent detection increases sensitivity.
Referring to
Referring to
The collimated evaporated droplets are then passed into the laser beam 18 where the analyte species in the sample is ionized. The ions are extracted and directed to a mass spectrometer (not shown) for analysis. The distance x between the exit of the collimator 17 and the laser beam 18 may be varied to adjust the sensitivity of the analysis. Typically the distance x will be in the range of about 12 to 0.5 centimeters.
The following example is provided for the purposes of illustration and is not intended to limit the scope of the invention.
Utilizing a modified photoionization/REMPI system as shown in
The present invention of this application is not only in pharmacokinetics, but also in other fields as well, including, but not limited to medical/health applications.
This application claims priority under 35 U.S.C. §119(e) from U.S. Provisional Patent Application No. 60/467,162 filed on Apr. 29, 2003 by Oser, et al. and entitled, “DIRECT LIQUID INJECTION INLET TO A LASER PHOTOIONIZATION APPARATUS,” which is incorporated by reference for all purposes.
The invention was made with Government support under grant number N01-CM-87101 awarded by the Department of Health and Human Services, and the National Cancer Institute. The Government has certain fights in this invention.
Number | Name | Date | Kind |
---|---|---|---|
4358302 | Dahneke | Nov 1982 | A |
5285064 | Willoughby | Feb 1994 | A |
5917185 | Yeung et al. | Jun 1999 | A |
6140639 | Gusev et al. | Oct 2000 | A |
6534765 | Robb et al. | Mar 2003 | B1 |
6646257 | Fischer et al. | Nov 2003 | B1 |
6858841 | Truche et al. | Feb 2005 | B1 |
20040046126 | Fisher | Mar 2004 | A1 |
Number | Date | Country |
---|---|---|
1193730 | Apr 2002 | EP |
Number | Date | Country | |
---|---|---|---|
20040222373 A1 | Nov 2004 | US |
Number | Date | Country | |
---|---|---|---|
60467162 | Apr 2003 | US |